US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Fluconazole Injection

Reason Labeling: Label mix-up - A complaint was received of one bag of Fluconazole Injection, Iso-Osmotic Sodium Chloride Diluent, USP, 2mg/mL, 50 mL found within the package of 100 mL bags.

Renaissance Lakewood, LLC NDC 36000-002-10 D-0696-2018
Class III · Low risk Terminated

Atropine Sulfate Ophthalmic 1% Solution

Reason Failed Stability Specification: OOS low viscosity results discovered during retain testing.

Akorn, Inc. D-0577-2018
Class II · Moderate risk Terminated

Labetalol Hydrochloride Injection

Reason Defective Container: Cracked glass at the rim surface of glass vials, covered by the stopper and crimp seal.

Hospira Inc. A Pfizer Company NDC 0409-2267-20 D-0576-2018
Class II · Moderate risk Terminated

Vardenafil HCl

Reason cGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

Kalchem International, Inc. NDC 60592-330-05 D-0582-2018
Class II · Moderate risk Terminated

0.9% Sodium Chloride Irrigation USP

Reason Presence of Particulate Matter: Customer complaint of particulate matter which has been identified as polyethylene, which is consistent with the material used to manufacture the container cap was received.

B. Braun Medical Inc NDC 0264-2201-00 D-0549-2018
Class II · Moderate risk Terminated

PVP Scrub Solution

Reason Subpotent Drug: product not meeting the iodine assay level requirements through the labeled expiry.

Medline Industries Inc NDC 53329-938-04 D-0546-2018
Class I · High risk Terminated

Bella Capsules

Reason Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.

Bella All Natural D-0593-2018
Class III · Low risk Terminated

Cystaran

Reason Subpotent Drug: Out of specification for an active ingredient cysteamine hydrochloride.

Leadiant Biosciences, INC NDC 54482-020-01 D-0550-2018
Class II · Moderate risk Terminated

SyrSpend SF Suspending Base

Reason Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).

Fagron, Inc NDC 51552-1079-5 D-0547-2018
Class II · Moderate risk Terminated

Valacyclovir Tablets USP 1 gram

Reason Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Hetero Labs Limited Unit V NDC 31722-705-30 D-0602-2018
Class II · Moderate risk Terminated

Valganciclovir Tablets

Reason Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir Tablets USP 1 gram were exposed to higher temperature at airport or cargo and in the same consignment of Famciclovir complaint batch (D-0415-2018).

Hetero Labs Limited Unit V NDC 31722-832-60 D-0601-2018
Class III · Low risk Terminated

Calcium Acetate Capsules

Reason Presence of Foreign Tablets/Capsules

Nostrum Laboratories Inc NDC 29033-026-02 D-0473-2018
Class II · Moderate risk Terminated

Acyclovir Tablets

Reason Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

Apace KY LLC NDC 50268-061-11 D-0544-2018
Class II · Moderate risk Terminated

Fluticasone propionate USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8276-3 D-0539-2018
Class II · Moderate risk Terminated

Cyanocobalamin USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8044-1 D-0538-2018
Class II · Moderate risk Terminated

Methylcobalamin

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8142-1 D-0537-2018
Class II · Moderate risk Terminated

Biotin USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8142-1 D-0536-2018
Class II · Moderate risk Terminated

Ascorbic Acid USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8120-6 D-0535-2018
Class II · Moderate risk Terminated

Verapamil HCl USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8039-6 D-0534-2018
Class II · Moderate risk Terminated

Vardenafil HCl USP

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8575-2 D-0533-2018
Class II · Moderate risk Terminated

Vancomycin HCl USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8091-4 D-0532-2018
Class II · Moderate risk Terminated

Ursodiol USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8038-6 D-0531-2018
Class II · Moderate risk Terminated

Tretinoin USP for prescription compounding

Reason CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

American Pharmaceutical Ingredients LLC NDC 58597-8033-2 D-0530-2018